Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.
D058186:Acute Kidney Injury / Q000139:chemically induced; D007516:Adenoma, Islet Cell / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011507:Proteinuria / Q000139:chemically induced; D013311:Streptozocin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D013311:Streptozocin